Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Francisco Díaz is active.

Publication


Featured researches published by Francisco Díaz.


Journal of Pharmacy and Pharmacology | 1999

Synthesis and hypolipidaemic evaluation of a series of α-asarone analogues related to clofibrate in mice

Fernando Labarrios; Leticia Garduño; Maria Del Rosario Vidal; Raúl García; María Salazar; Elizdath Martínez; Francisco Díaz; Germán Chamorro; Joaquín Tamariz

A series of α‐asarone analogues related to clofibrate, containing an acetic acid group at C‐2 of the aromatic ring, has been prepared as the acids or as the ethyl and methyl esters. The corresponding alcohols were also synthesized by reduction of the ethyl esters. The compounds were examined in hyperlipidaemic male mice to evaluate their ability to modify serum lipoprotein cholesterol, low‐density lipoprotein cholesterol, high‐density lipoprotein cholesterol and triglycerides after oral administration of 40 and 80 mg kg−1 for 6 days.


Drug Development Research | 1998

Hypolipidaemic activity of dimethoxy unconjugated propenyl side‐chain analogs of α‐asarone in mice

Germán Chamorro; Leticia Garduño; Adrián Sánchez; Fernando Labarrios; María Salazar; Elizdath Martínez; Francisco Díaz; Joaquín Tamariz

The hypolipidaemic activity of several dimethoxy unconjugated propenyl side‐chain analogs of α‐asarone were investigated in hyperlipidaemic mice after six days of treatment. Eugenol and the α‐asarone analog with amino groups on the C‐4 position of the aromatic ring were observed to be the most effective hypolipidaemic agents at the dose of 80 mg/kg/day p.o. These compounds significantly lowered total serum cholesterol, low density lipoprotein (LDL‐cholesterol), and triglycerides content. On the other hand, high density lipoprotein (HDL‐cholesterol) was increased by administration of these hypolipidaemic agents. The ability to modulate the levels of these lipids suggests that these agents could be effective in the treatment of hyperlipidaemic states. These compounds appeared to be safe when administered at an oral dose of 80 mg/kg/day, which is within the therapeutic range in mice. Drug Dev. Res. 43:105–108, 1998.


Phytotherapy Research | 1999

Dominant lethal study of α-asarone in male and female mice after sub-chronic treatment

Germán Chamorro; María Salazar; Joaquín Tamariz; Francisco Díaz; Fernando Labarrios

Dominant lethal studies were conducted in male and female mice with α‐asarone, the active hypolipidaemic component of Guatteria gaumeri Greenman, by per os sub‐chronic treatment (10 and 20 mg/kg, 5 days/week, for 8 weeks) and subsequent mating. α‐Asarone did not produce germinal mutations in either males or females. Epididymal sperm examination of male mice immediately after treatment failed toreveal any alteration in sperm count on shape. No significant alterations were observed in testicular or epididymal weights or testicular histology. Copyright


Organic Preparations and Procedures International | 1991

AN EFFICIENT SYNTHESIS OF α-ASARONE

Francisco Díaz; Leticia Contreras; Rosa Flores; Joaquín Tamariz; Fernando Labarrios; Germán Chamorro; Héber Muñoz


Drug Development Research | 2004

Potent hypolipidemic activity of mimetic amides of fibrates based on the 2‐methoxy‐4‐(2‐propenyl)phenoxyacetic scaffold

Dolores Hernández; Pablo Bernal; Adriana Cruz; Yésica Garciafigueroa; Leticia Garduño; María Salazar; Francisco Díaz; Germán Chamorro; Joaquín Tamariz


Biomedica | 2009

Actividad inducida por androsterona y hemisuccinato de androsterona sobre la presión de perfusión y la resistencia vascular

Lauro Figueroa; Francisco Díaz; Abelardo Camacho; Eliseo Díaz; Rolando Marvin


Medicinal Chemistry Research | 2001

High hypolipidemic activity of saturated side-chain α-asarone analogs

Adriana Cruz; Leticia Garduño; María Salazar; Elizdath Martínez; Francisco Díaz; Germán Chamorro; Joaquín Tamariz


Drug Development Research | 2003

Hypolipidemic Activity of New Phenoxyacetic Derivatives Related to α-Asarone with Minimal Pharmacophore Features

María del Carmen Cruz; María Salazar; Yésica Garciafigueroa; Dolores Hernández; Francisco Díaz; Germán Chamorro; Joaquín Tamariz


Drug Research | 2011

Synthesis and Hypolipidemic Activity of Modified Side Chain α-Asarone Homologues

Adriana Cruz; Leticia Garduño; María Salazar; Elizdath Martínez; Hugo A. Jiménez-Vázquez; Francisco Díaz; Germán Chamorro; Joaquín Tamariz


ChemInform | 1994

Synthesis and Hypolipidemic Activity of Some α-Asarone Analogues.

Francisco Díaz; H. Munoz; Fernando Labarrios; Germán Chamorro; M. Salazar; M. E. Morelos; Joaquín Tamariz

Collaboration


Dive into the Francisco Díaz's collaboration.

Top Co-Authors

Avatar

Joaquín Tamariz

Instituto Politécnico Nacional

View shared research outputs
Top Co-Authors

Avatar

Germán Chamorro

Instituto Politécnico Nacional

View shared research outputs
Top Co-Authors

Avatar

María Salazar

Instituto Politécnico Nacional

View shared research outputs
Top Co-Authors

Avatar

Fernando Labarrios

Instituto Politécnico Nacional

View shared research outputs
Top Co-Authors

Avatar

Leticia Garduño

Instituto Politécnico Nacional

View shared research outputs
Top Co-Authors

Avatar

Elizdath Martínez

Instituto Politécnico Nacional

View shared research outputs
Top Co-Authors

Avatar

Adriana Cruz

Instituto Politécnico Nacional

View shared research outputs
Top Co-Authors

Avatar

Blanca M. Santoyo

Instituto Politécnico Nacional

View shared research outputs
Top Co-Authors

Avatar

Dolores Hernández

Instituto Politécnico Nacional

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge